No recent analyst price targets found for IPCIF.
Latest News for IPCIF
Reviewing Intellipharmaceutics International (OTCMKTS:IPCIF) & Neoleukin Therapeutics (NASDAQ:NLTX)
Valuation and Earnings This table compares Neoleukin Therapeutics and Intellipharmaceutics International"s revenue, earnings per share (EPS) and valuation. Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Neoleukin Therapeutics N/A N/A -$57.56 million ($3.11) -5.68 Intellipharmaceutics International $660,000.00 0.00 -$2.89 million ($0.16) N/A Intellipharmaceutics International has…
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for IPCIF.
Senate Trading
No Senate trades found for IPCIF.
U.S. House Trading
No House trades found for IPCIF.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.